000			02356 a2200661 4500
005			20250515113931.0
264		0	_c20080718
008			200807s 0 0 eng d
022			_a1535-7163
024	7		_a10.1158/1535-7163.MCT-07-0302 _2doi
040			_aNLM _beng _cNLM
100	1		_aTucker, Catherine A
245	0	0	_aSilencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-kappaB, p53, bax, and p27 levels. _h[electronic resource]
260			_bMolecular cancer therapeutics _cApr 2008
300			_a749-58 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aApoptosis _xphysiology
650	0	4	_aBlotting, Western
650	0	4	_aCell Proliferation
650	0	4	_aCyclin D
650	0	4	_aCyclin-Dependent Kinase Inhibitor p27 _xgenetics
650	0	4	_aCyclins _xgenetics
650	0	4	_aDNA-Binding Proteins _xgenetics
650	0	4	_aDisease Models, Animal
650	0	4	_aGene Silencing
650	0	4	_aHumans
650	0	4	_aImmunoenzyme Techniques
650	0	4	_aImmunoprecipitation
650	0	4	_aLymphoma, Mantle-Cell _xgenetics
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Knockout
650	0	4	_aMice, Transgenic
650	0	4	_aNF-kappa B _xgenetics
650	0	4	_aNeoplasm Proteins _xgenetics
650	0	4	_aOligonucleotides, Antisense _xpharmacology
650	0	4	_aPhosphorylation
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors
650	0	4	_aProto-Oncogene Proteins c-mdm2 _xmetabolism
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction
650	0	4	_aThionucleotides _xpharmacology
650	0	4	_aTumor Suppressor Protein p53 _xgenetics
650	0	4	_aXenograft Model Antitumor Assays
650	0	4	_abcl-2-Associated X Protein _xgenetics
700	1		_aKapanen, Anita I
700	1		_aChikh, Ghania
700	1		_aHoffman, Brad G
700	1		_aKyle, Alastair H
700	1		_aWilson, Ian M
700	1		_aMasin, Dana
700	1		_aGascoyne, Randy D
700	1		_aBally, Marcel
700	1		_aKlasa, Richard J
773	0		_tMolecular cancer therapeutics _gvol. 7 _gno. 4 _gp. 749-58
856	4	0	_uhttps://doi.org/10.1158/1535-7163.MCT-07-0302 _zAvailable from publisher's website
999			_c17875635 _d17875635